Submission Details
| 510(k) Number | K860049 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 06, 1986 |
| Decision Date | January 22, 1986 |
| Days to Decision | 16 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
K860049 is an FDA 510(k) clearance for the DETERMINATION OF QUINIDINE, a Enzyme Immunoassay, Quinidine (Class II — Special Controls, product code LBZ), submitted by Clinical Data, Inc. (Boston, US). The FDA issued a Cleared decision on January 22, 1986, 16 days after receiving the submission on January 6, 1986. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3320.
| 510(k) Number | K860049 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 06, 1986 |
| Decision Date | January 22, 1986 |
| Days to Decision | 16 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
| Product Code | LBZ — Enzyme Immunoassay, Quinidine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3320 |